Botulinum toxin for the treatment of gastrointestinal disorders
HAYES, Inc.
Record ID 32004000364
English
Authors' objectives:
Botulinum toxin (BTX) is used for the endoscopic treatment of gastrointestinal disorders that are characterized by sphincteric spasticity. BTX is injected directly into affected muscles in order to produce chemical denervation of the abnormally functioning muscles by blocking synaptic transmission. This relaxes the muscle and causes a temporary relief of symptoms.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.hayesinc.com/
Year Published:
2003
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Botulinum Toxins
- Gastrointestinal Diseases
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.